Cleveland Clinic Foundation

Overview

The mission of the Cleveland Clinic's Blood and Marrow Transplant Program is to provide high-quality specialized care to patients receiving transplant and cell therapies in a setting of education and research. We embrace the values of initiative, innovation, collaboration, confidentiality, empathy and integrity. The best in high-quality treatment, access to the latest technology and research, and our all-encompassing "Patients First" philosophy make us a leading cancer center. We have expertise in performing autologous and allogeneic transplantation in children and adults with malignant and non-malignant diseases, and offer specialized transplantation procedures such as umbilical cord blood transplant, haploidentical transplant and cellular therapy. We are a certified center for Abecma, Carvykti, Breyanzi, Tecartus, Yescarta and Kymriah Chimeric Antigen Receptor (CAR T-cell) Therapy. Learn more about our Blood and Marrow Transplant Program at clevelandclinic.org/BMT.

This center has been performing allogeneic transplants since 1977 and has been an NMDP transplant center since December 1988.

Attending physicians

Adult - Faiz Anwer, Claudio Brunstein, Paolo Caimi, Robert Dean, Betty Ky Hamilton, Brian Hill, Deepa Jagadeesh, Matt Kalaycio, Jack Khouri, Brad Pohlman, Craig Sauter, Ronald Sobecks, Louis Williams, Allison Winter
Pediatric - Ilia Buhtroiarov, Rabi Hanna, Seth Rotz

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants

Adult and pediatric

Other programs and services

The Cleveland Clinic Blood & Marrow Transplant Program has many additional supportive services to aide patient & family caregivers through the transplant process. Supportive services include: -Dedicated BMT Social Workers (4 adult & 1 pediatric) -Multi-disciplinary patient education to prepare patients for discharge from transplant admission, educational materials are on paper and also available online -Nearby accommodations at American Cancer Society Hope Lodge for most patients at no charge -Ronald McDonald House is adjacent to hospital campus at a nominal fee for families of pediatric patients -Various local hotels offer discount rates, all provide shuttle service to hospital campus -Participation in the NMDP Caregiver Companion Program -Dedicated Adult Inpatient Music Therapist -Extensive Spiritual Care Services both inpatient & outpatient (Chaplains available from many faiths) -Many outpatient services including: 4th Angel Mentoring Program; Educational Resource Center (pamphlets, brochures, computer terminals for searches, WiFi for internet access and conference area for discussion with Cancer Center Personnel), Nutritional Counseling, Chemotherapy Education; Patient Liaison for immediate non-medical issues; Reflections Programs (a wellness program offers patients the opportunity to be pampered, regain a sense of control over cancer or take a special moment for him/herself); Art Therapy; Complimentary Wig Boutique; Fertility Preservation Counseling and Services; For pediatric patients there is an on-sight public school teacher and classroom (or can go to patient's room if necessary) assisting students to keep current with their school work.

Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center*.

The survival information we have for this center includes ONLY:

Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
Who had their transplant at a U.S. transplant center, and
Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 285 patients.

The actual 1-year survival of these patients is 71.6%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 70.8% and 80.4%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report

at bloodcell.transplant.hrsa.gov.

* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.

The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.

Total adult transplants

512

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 20	PBSC 40	Cord blood 0	Total 60
Unrelated donor	Marrow 22	PBSC 115	Cord blood 2	Total 139
Total allogeneic	Marrow 42	PBSC 155	Cord blood 2	Total 199
Autologous	Marrow Both marrow & PBSC 313	PBSC —	Cord blood —	Total 313
Total combined	Marrow Both marrow & PBSC 510	PBSC —	Cord blood 2	Total 512

Total pediatric transplants

10

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 3	PBSC 0	Cord blood 0	Total 3
Unrelated donor	Marrow 1	PBSC 0	Cord blood 2	Total 3
Total allogeneic	Marrow 4	PBSC 0	Cord blood 2	Total 6
Autologous	Marrow Both marrow & PBSC 4	PBSC —	Cord blood —	Total 4
Total combined	Marrow Both marrow & PBSC 8	PBSC —	Cord blood 2	Total 10

All Diseases

Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)

	0-18	19-44	45-64	65+	Total
Related	0-18 3	19-44 13	45-64 27	65+ 20	Total 63
Unrelated	0-18 3	19-44 23	45-64 56	65+ 60	Total 142
Autologous	0-18 4	19-44 52	45-64 156	65+ 105	Total 317
Total	0-18 10	19-44 88	45-64 239	65+ 185	Total 522

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants can be found:

U.S. Transplant Data by Center (Opens in a new tab)
report at blood cell.transplant.hrsa.gov
List of diseases

Transplant center resources

Transplant center coordinator

Brittany Hodgeman

Phone: 216-213-7356

Email: hodgemb@ccf.org

Financial representative

Vanessa Hudson

Phone: (216) 445-6659

Email: hudsonv@ccf.org

NMDP patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

More resources

Choosing a transplant center
Preparing for transplant
Learn about transplant outcomes and treatment decisions (Opens in a new tab)
Support and resources (including non-English materials)
U.S. Transplant Data by Center (Opens in a new tab)
at blood cell.transplant.hrsa.gov

This center has separate survivorship programs for adult and pediatric patients.

Please select the program you are interested in.